Chronic Somogyi rebound

The Chronic Somogyi rebound, also known as the Somogyi effect, is a phenomenon observed in individuals with diabetes mellitus, particularly those who are insulin-dependent. It is characterized by a pattern of hypoglycemia followed by rebound hyperglycemia. This effect is named after Dr. Michael Somogyi, a Hungarian-born American biochemist who first described the phenomenon.

Pathophysiology

The Somogyi effect occurs when an excessive dose of insulin causes a drop in blood glucose levels during the night, leading to hypoglycemia. In response to this low blood sugar, the body releases counterregulatory hormones such as glucagon, epinephrine, cortisol, and growth hormone. These hormones stimulate gluconeogenesis and glycogenolysis, resulting in an increase in blood glucose levels, or hyperglycemia, by the morning.

Clinical Presentation

Patients experiencing the Somogyi effect may report symptoms of nocturnal hypoglycemia, such as night sweats, nightmares, or restless sleep. Upon waking, they may experience symptoms of hyperglycemia, including fatigue, headache, and blurred vision.

Diagnosis

Diagnosing the Somogyi effect involves monitoring blood glucose levels throughout the night. Patients are advised to check their blood sugar at bedtime, during the night (typically around 2-3 AM), and upon waking. A pattern of low blood sugar during the night followed by high blood sugar in the morning suggests the presence of the Somogyi effect.

Management

Management of the Somogyi effect involves adjusting the insulin regimen to prevent nocturnal hypoglycemia. This may include reducing the dose of long-acting insulin or changing the timing of insulin administration. Patients are also advised to have a bedtime snack to help maintain stable blood glucose levels overnight.

Related pages

• Diabetes mellitus
• Hypoglycemia
• Hyperglycemia
• Insulin therapy